thrombocytopeny. Idiopathic thrombocytopenic purpura
Conditions
Interventions
Intervention 1: Intervention:clarithromycin 500 mg ,Amoxicillin 1000 mg, Omeprazol 20 mg /PO/ BD. Intervention 2: Control group:Treatment with Placebo twice a day for 14 days.
Treatment - Drugs
Placebo
Intervention:clarithromycin 500 mg ,Amoxicillin 1000 mg, Omeprazol 20 mg /PO/ BD.
Control group:Treatment with Placebo twice a day for 14 days
Sponsors
Vice Chancellor for Research and Technology, Babol University of Medical Sciences
Eligibility
Sex/Gender
All
Age
15 Years to 60 Years
Inclusion criteria
Inclusion criteria: Inclusive Criteria: Adult with diagnosis of idiopathic thrombocytopenic purpura; H. pylori stool antigen test Positive or positive urease breath test Exclusive Criteria: Family history of gastric cancer;History of treatment of H.Pylori infection; History of ulcer or inflammation in stomach or Duodenum.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Platelet count over than 100000. Timepoint: day 0,10,30,60,90,120,150,180 after drug. Method of measurement: Laboratory. | — |
Secondary
| Measure | Time frame |
|---|---|
| Efficacy of treatment in eradication of H-Pylori. Timepoint: during 6 months(in days 0,10,30,60,90,120) after drug. Method of measurement: Laboratory. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactBabak Yeganeh
Tropical and infectious diseases research center, Babol University Of Medical Sciences
Outcome results
None listed